Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 26, 2022
Streptococcus
is
widely
found
in
nature
and
the
human
body,
most
species
are
not
pathogenic.
In
recent
years,
studies
have
that
associated
with
gastric
cancer.
was
to
be
enriched
oral
cavity,
stomach
intestine
of
cancer
patients
increased
tissues,
suggesting
may
pathogenic
bacteria
underlying
This
review
discusses
discovery
Streptococcus,
relationship
between
cancer,
possible
carcinogenic
mechanism
summarizes
progress
research
on
role
provide
new
ideas
for
early
detection,
diagnosis
treatment
World Journal of Gastroenterology,
Journal Year:
2023,
Volume and Issue:
29(16), P. 2452 - 2468
Published: April 24, 2023
Gastric
cancer
(GC)
is
defined
as
the
primary
epithelial
malignancy
derived
from
stomach,
and
it
a
complicated
heterogeneous
disease
with
multiple
risk
factors.
Despite
its
overall
declining
trend
of
incidence
mortality
in
various
countries
over
past
few
decades,
GC
remains
fifth
most
common
fourth
leading
cause
cancer-related
death
globally.
Although
global
burden
has
shown
significant
downward
trend,
severe
certain
areas,
such
Asia.
ranks
third
among
all
types
China,
accounts
for
nearly
44.0%
48.6%
new
cases
GC-related
deaths
world,
respectively.
The
regional
differences
are
obvious,
annual
increasing
rapidly
some
developing
regions.
Therefore,
early
preventive
screening
strategies
urgently
needed.
clinical
efficacies
conventional
treatments
limited,
understanding
pathogenesis
increased
demand
therapeutic
regimens,
including
immune
checkpoint
inhibitors,
cell
immunotherapy
vaccines.
present
review
describes
epidemiology
worldwide,
especially
summarizes
prognostic
factors,
focuses
on
novel
immunotherapies
to
develop
management
patients.
Gut,
Journal Year:
2024,
Volume and Issue:
unknown, P. gutjnl - 331164
Published: Feb. 21, 2024
At
the
end
of
last
century,
a
far-sighted
‘working
party’
held
in
Sydney,
Australia
addressed
clinicopathological
issues
related
to
gastric
inflammatory
diseases.
A
few
years
later,
an
international
conference
Houston,
Texas,
USA
critically
updated
seminal
Sydney
classification.
In
line
with
these
initiatives,
Kyoto
Global
Consensus
Report,
flanked
by
Maastricht-Florence
conferences,
added
new
clinical
evidence
gastritis
puzzle.
The
most
relevant
topics
diseases
have
been
Real-world
Gastritis
Initiative
(RE.GA.IN.),
from
disease
definitions
diagnosis
and
prognosis.
This
paper
reports
conclusions
RE.GA.IN.
consensus
process,
which
culminated
Venice
November
2022
after
more
than
8
months
intense
global
scientific
deliberations.
forum
scholars
five
continents
participated
multidisciplinary
consensus.
After
lively
debates
on
controversial
aspects
spectrum,
Faculty
amalgamated
complementary
knowledge
distil
patient-centred,
evidence-based
statements
assist
health
professionals
their
real-world
practice.
sections
this
report
focus
on:
epidemiology
gastritis;
Helicobacter
pylori
as
dominant
aetiology
environmental
important
determinant
oncogenetic
field;
evolving
autoimmunity;
relevance
microbiota;
diagnostic
horizons
endoscopy;
priority
histologically
reporting
terms
staging.
ultimate
goal
was
remains
promotion
further
improvement
management
patients
gastritis.
npj Biofilms and Microbiomes,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Jan. 2, 2025
Emerging
evidence
indicates
that
oral
microbes
are
closely
related
to
gastric
and
lesions,
including
atrophy,
intestinal
metaplasia
cancer
(GC).
Helicobacter
pylori
is
a
key
pathogen
involved
in
GC.
However,
the
increasing
prevalence
of
H.
pylori-negative
GC
dysbiosis
patients
emphasize
potential
role
other
microbial
factors.
In
this
review,
we
discussed
current
about
relationship
between
oral–gastric
axis
health.
Epidemiologic
poor
hygiene
greater
risk.
Multiple
oral-associated
enriched
stomach
patients.
Once
colonizing
stomach,
Streptococcus
anginosus
Prevotella
melaninogenica,
inflammation
or
carcinogenesis.
Microbial
metabolites
such
as
lactate,
nitrite,
acetaldehyde
promote
malignant
transformation.
The
checkpoint
transmission
digestive
tract,
great
importance
since
link
diseases
has
been
emphasized.
Still,
new
technologies
standardized
metrics
necessary
identify
pathogenetic
for
core
microbiota,
interactions,
richness,
colonization,
location
effect
(CIRCLE).
future,
could
be
candidates
noninvasive
indicators
predict
diseases.
Journal of Agricultural and Food Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 10, 2025
Edible
and
medicinal
mushroom
polysaccharides
(EMMPs)
have
been
widely
studied
for
their
various
biological
activities.
It
has
shown
that
EMMPs
could
modulate
microbiota
in
the
large
intestine
improve
intestinal
health.
However,
role
of
protecting
gastric
barrier,
regulating
microbiota,
improving
health
cannot
be
ignored.
Hence,
this
review
will
elucidate
effect
on
barriers,
with
emphasis
interaction
maintaining
overall
gastrointestinal
Additionally,
highlights
gastroprotective
effects
underlying
mechanisms
against
mucosa
injury,
gastritis,
ulcer,
cancer.
Furthermore,
diseases,
including
inflammatory
bowel
disease,
colorectal
cancer,
infection,
are
also
summarized.
This
discuss
future
perspective
challenges
use
as
a
dietary
supplement
or
nutraceutical
preventing
treating
diseases.
World Journal of Gastroenterology,
Journal Year:
2024,
Volume and Issue:
30(8), P. 779 - 793
Published: Feb. 26, 2024
In
this
editorial,
we
comment
on
the
article
entitled
"Advances
and
key
focus
areas
in
gastric
cancer
immunotherapy:
A
comprehensive
scientometric
clinical
trial
review
(1999-2023),"
which
was
published
recent
issue
of
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: Sept. 29, 2023
The
stomach
was
once
considered
a
sterile
organ
until
the
discovery
of
Helicobacter
pylori
(HP)
.
With
application
high-throughput
sequencing
technology
and
macrogenomics,
researchers
have
identified
fungi
fivemajor
bacterial
phyla
within
stomachs
healthy
individuals.
These
microbial
communities
exert
regulatory
influence
over
various
physiological
functions,
including
energy
metabolism
immune
responses.
HP
is
well-recognized
risk
factor
for
gastric
cancer,
significantly
altering
stomach’s
native
microecology.
Currently,
numerous
studies
are
centered
on
mechanisms
by
which
contributes
to
cancer
development,
primarily
involving
CagA
oncoprotein.
However,
aside
from
exogenous
infections
such
as
EBV,
certain
endogenous
dysbiosis
can
also
lead
through
multiple
mechanisms.
Additionally,
gut
microbiota
its
metabolites
impact
development
cancer.
role
therapies,
diet,
phages,
probiotics
fecal
transplantation,
in
treating
should
not
be
underestimated.
This
review
aims
study
involved
roles
pathogen
infection
Also,
we
describe
therapy
treatment
prognosis
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 22, 2024
Gastric
cancer
(GC)
is
a
malignant
neoplasm
originating
from
the
epithelial
cells
of
gastric
mucosa.
The
pathogenesis
GC
intricately
linked
to
tumor
microenvironment
within
which
reside.
Tumor-associated
macrophages
(TAMs)
primarily
differentiate
peripheral
blood
monocytes
and
can
be
broadly
categorized
into
M1
M2
subtypes.
M2-type
TAMs
have
been
shown
promote
growth,
tissue
remodeling,
angiogenesis.
Furthermore,
they
actively
suppress
acquired
immunity,
leading
poorer
prognosis
reduced
tolerance
chemotherapy.
Exosomes,
contain
myriad
biologically
active
molecules
including
lipids,
proteins,
mRNA,
noncoding
RNAs,
emerged
as
key
mediators
communication
between
TAMs.
exchange
these
via
exosomes
markedly
influence
consequently
impact
progression.
Recent
studies
elucidated
correlation
various
clinicopathological
parameters
GC,
such
size,
differentiation,
infiltration
depth,
lymph
node
metastasis,
TNM
staging,
highlighting
pivotal
role
in
development
metastasis.
In
this
review,
we
aim
comprehensively
examine
bidirectional
TAMs,
implications
alterations
on
immune
escape,
invasion,
metastasis
targeted
therapeutic
approaches
for
efficacy
potential
drug
resistance
strategies.